Investing.com - Deciphera Pharma (NASDAQ: DCPH) reported fourth quarter EPS of $-0.60, $0.03 worse than the analyst estimate of $-0.57. Revenue for the quarter came in at $36.35M versus the consensus estimate of $35.67M.
Deciphera Pharma's stock price closed at $16.71. It is up 2.26% in the last 3 months and up 104.78% in the last 12 months.
Deciphera Pharma saw 5 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Deciphera Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, Deciphera Pharma's Financial Health score is "good performance".
Check out Deciphera Pharma's recent earnings performance, and Deciphera Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar